A Study of Effectiveness of Low Dose versus Standard Dose Intravenous Recombinant Tissue-type Plasminogen Activator in Acute Ischemic Stroke in Phramongkutklao Hospital
Evaluation of the efficacy of recombinant tissue plasminogen activators in improving clinical status of acute ischemic stroke: A randomized clinical trial in Iran